Profile
Chris Angelatos currently holds the position of Senior Analyst at Esplanade Ventures.
Additionally, Mr. Angelatos is Vice President at Vistara Capital Partners Ltd., with the title starting in 2025.
Mr. Angelatos completed an undergraduate degree at Queens University (Bangladesh) in 2016.
Chris Angelatos active positions
| Companies | Position | Start |
|---|---|---|
Esplanade Ventures
Esplanade Ventures Investment ManagersFinance Esplanade Ventures invests in companies located in North America. The firm focuses on the healthcare sector such as digital health focus and preference for AI software. It participates in seed, early and growth stage capital requirements. The firm acts as a lead investor and makes follow-on investments. It does not invest in invasive devices or biotech companies. | Private Equity Analyst | - |
Vistara Capital Partners Ltd.
Vistara Capital Partners Ltd. Investment ManagersFinance Vistara Capital Partners invests in mid-later stage technology companies located across the North America and Select International Markets with revenues of at least USD 10 million. The firm targets companies operating in the field of software & technology enabled services. It invests in the form of equity and debt for minority capital, primary and secondary capital, hybrid instruments and growth capital requirements with an investment size of USD 10 million - USD 30 million per company. | Private Equity Investor | 01/01/2025 |
Training of Chris Angelatos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Queens University (Bangladesh)
Queens University (Bangladesh) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vistara Capital Partners Ltd.
Vistara Capital Partners Ltd. Investment ManagersFinance Vistara Capital Partners invests in mid-later stage technology companies located across the North America and Select International Markets with revenues of at least USD 10 million. The firm targets companies operating in the field of software & technology enabled services. It invests in the form of equity and debt for minority capital, primary and secondary capital, hybrid instruments and growth capital requirements with an investment size of USD 10 million - USD 30 million per company. | Finance |
Esplanade Ventures
Esplanade Ventures Investment ManagersFinance Esplanade Ventures invests in companies located in North America. The firm focuses on the healthcare sector such as digital health focus and preference for AI software. It participates in seed, early and growth stage capital requirements. The firm acts as a lead investor and makes follow-on investments. It does not invest in invasive devices or biotech companies. | Finance |
- Stock Market
- Insiders
- Chris Angelatos
















